
Royal Sense launches 17 new pharmaceutical products
Royal Sense Ltd has announced the launch of 17 new pharmaceutical products, available for sale from April 27, 2026. The new product line includes various health supplements such as Cholecalciferol Nano Shot, Stergivita Caps/Syrup, Lycoseven Caps/Syrup, and several 'Shakti' and 'Detox' products. These products are categorized as pharmaceuticals and are intended for the domestic market. The company provided detailed information for its "New Cholecacirol Nano Shot," highlighting its sugar-free, fast-absorbing nano-technology formulation for Vitamin D3 deficiency, targeting a significant and growing market segment in India (estimated ₹250-350 Crore for oral solution/nano shot Vitamin D3, growing at 12-15% CAGR). The launch aims to capitalize on the high prevalence of Vitamin D deficiency and increasing demand for convenient dosage forms.
Key Highlights
- Royal Sense launched 17 new pharmaceutical products on April 27, 2026.
- New products include Cholecalciferol Nano Shot, Stergivita, and other health supplements.
- The Vitamin D3 nano shot targets a ₹250-350 Cr market, growing at 12-15% CAGR.
- This expansion aims to address high Vitamin D deficiency and market demand.